𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB)

✍ Scribed by Karsten Ulbrich; Telli Hekmatara; Elisabeth Herbert; Jörg Kreuter

Book ID
116438079
Publisher
Elsevier Science
Year
2009
Tongue
French
Weight
415 KB
Volume
71
Category
Article
ISSN
0939-6411

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Receptor-mediated transcytosis of transf
Receptor-mediated transcytosis of transferrin across the blood-brain barrier
✍ Dr. J. B. Fishman; J. B. Rubin; J. V. Handrahan; J. R. Connor; R. E. Fine 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

The perfusion of rat brain with '251-transferrin resulted in a receptor-mediated uptake of transferrin into the endothelium of the blood-brain barrier followed by its detection in the brain. During a pulsechase experiment, lZSI-transferrin accumulated in the endothelial cells during the pulse, with

Engineering and expression of a chimeric
Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood–brain barrier delivery in the mouse
✍ Ruben J. Boado; Yun Zhang; Yuntao Wang; William M. Pardridge 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 2 views

## Abstract Protein therapeutics may be delivered across the blood–brain barrier (BBB) by genetic fusion to a BBB molecular Trojan horse. The latter is an endogenous peptide or a peptidomimetic monoclonal antibody (MAb) against a BBB receptor, such as the insulin receptor or the transferrin recepto

Humanization of anti-human insulin recep
Humanization of anti-human insulin receptor antibody for drug targeting across the human blood–brain barrier
✍ Ruben J. Boado; Yufeng Zhang; Yun Zhang; William M. Pardridge 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

## Abstract A murine monoclonal antibody (MAb) to the human insulin receptor (HIR) has been engineered for use as a brain drug delivery system for transport across the human blood–brain barrier (BBB). The HIRMAb was humanized by complementarity determining region (CDR) grafting on the framework reg